Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases

Theranostics

Volumn 5, Issue 3, 2015, Pages 277-288

  Lux, Jacques ^a   White, Alexander G ^b   Chan, Minnie ^a   Anderson, Carolyn J ^b   Almutairi, Adah ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Copper 64; Metal chelating crosslinkers; Metastases; Nanogels; NOTA; PET; Preclinical imaging

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; CHELATING AGENT; COPPER 64; NANOGEL; NANOMATERIAL; PENTETIC ACID; POLYACRYLAMIDE GEL; TETRAXETAN; UNCLASSIFIED DRUG; COPPER; MACROGOL DERIVATIVE; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CHEMICAL LABELING; CHEMICAL STRUCTURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CROSS LINKING; EX VIVO STUDY; IN VIVO STUDY; LIVER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOACTIVITY; SPLEEN; SYNTHESIS; ANIMAL; DRUG STABILITY; HUMAN; NEOPLASM METASTASIS; NEOPLASMS; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ANIMALS; COPPER RADIOISOTOPES; DRUG STABILITY; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASMS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84924300069     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.10904     Document Type: Article

References (55)

1. Caravan P, Begley TP. Metals in Medicine: Imaging Agents. Wiley Encyclopedia of Chemical Biology: John Wiley & Sons, Inc.; 2007.
2. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem Rev. 1999; 99: 2293-352.
3. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev. 2006; 35: 512-23.
4. Anderson CJ, Welch MJ. Radiometal labeled agents (non-technetium) for diagnostic imaging. Chem Rev. 1999; 99: 2219-34.
5. Anderson CJ, Ferdani R. Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research. Cancer Biother Radiopharm. 2009; 24: 379-93.
6. Yu SB, Watson AD. Metal-based X-ray contrast media. Chem Rev. 1999; 99: 2353-77.
7. Lemieux P, Vinogradov SV, Gebhart CL, Guerin N, Paradis G, Nguyen HK, et al. Block and graft copolymers and Nanogel (TM) copolymer networks for DNA delivery into cell. J Drug Target. 2000; 8: 91-105.
8. Kabanov AV, Vinogradov SV. Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities. Angew Chem Int Ed Engl. 2009; 48: 5418-29.
9. Bronich TK, Vinogradov SV, Kabanov AV. Interaction of nanosized copolymer networks with oppositely charged amphiphilic molecules. Nano Lett. 2001; 1: 535-40.
10. Missirlis D, Kawamura R, Tirelli N, Hubbell JA. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci. 2006; 29: 120-9.
11. Kwon YJ, Standley SM, Goh SL, Frechet JMJ. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J Control Release. 2005; 105: 199-212.
12. Standley SM, Mende I, Goh SL, Kwon YJ, Beaudette TT, Engleman EG, et al. Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconj Chem. 2007; 18: 77-83.
13. Lux J, Chan MN, Elst LV, Schopf E, Mahmoud E, Laurent S, et al. Metal chelating crosslinkers form nanogels with high chelation stability. J Mater Chem B. 2013; 1: 6359-64.
14. Rossin R, Pan DPJ, Qi K, Turner JL, Sun XK, Wooley KL, et al. Cu-64-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: Synthesis, radiolabeling, and biologic evaluation. J Nucl Med. 2005; 46: 1210-8.
15. Xu JQ, Sun GR, Rossin R, Hagooly A, Li ZC, Fukukawa K, et al. Labeling of polymer nanostructures for medical imaging: Importance of cross-linking extent, spacer length, and charge density. Macromolecules. 2007; 40: 2971-3.
16. Pressly ED, Rossin R, Hagooly A, Fukukawa KI, Messmore BW, Welch MJ, et al. Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined Cu-64-labeled nanoparticles comprised of amphiphilic block graft copolymers. Biomacromolecules. 2007; 8: 3126-34.
17. Nahrendorf M, Zhang HW, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation. 2008; 117: 379-87.
18. Rossin R, Muro S, Welch MJ, Muzykantov VR, Schuster DP. In vivo imaging of Cu-64-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med. 2008; 49: 103-11.
19. Zhou M, Zhang R, Huang MA, Lu W, Song SL, Melancon MP, et al. A Chelator-Free Multifunctional [Cu-64]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy. J Am Chem Soc. 2010; 132: 15351-8.
20. Yang XQ, Hong H, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, et al. cRGD-functionalized, DOX-conjugated, and Cu-64-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials. 2011; 32: 4151-60.
21. Shokeen M, Pressly ED, Hagooly A, Zheleznyak A, Ramos N, Fiamengo AL, et al. Evaluation of Multivalent, Functional Polymeric Nanoparticles for Imaging Applications. ACS Nano. 2011; 5: 738-47.
22. Zeng DX, Lee NS, Liu YJ, Zhou D, Dence CS, Wooley KL, et al. Cu-64 Core-Labeled Nanoparticles with High Specific Activity via Metal-Free Click Chemistry. ACS Nano. 2012; 6: 5209-19.
23. Lee DE, Na JH, Lee S, Kang CM, Kim HN, Han SJ, et al. Facile Method To Radiolabel Glycol Chitosan Nanoparticles with Cu-64 via Copper-Free Click Chemistry for MicroPET Imaging. Mol Pharm. 2013; 10: 2190-8.
24. Pressly ED, Pierce RA, Connal LA, Hawker CJ, Liu YJ. Nanoparticle PET/CT Imaging of Natriuretic Peptide Clearance Receptor in Prostate Cancer. Bioconj Chem. 2013; 24: 196-204.
25. Lee S, Kang SW, Ryu JH, Na JH, Lee DE, Han SJ, et al. Tumor-Homing Glycol Chitosan-Based Optical/PET Dual Imaging Nanoprobe for Cancer Diagnosis. Bioconj Chem. 2014; 25: 601-10.
26. Zhao YF, Sultan D, Detering L, Cho SH, Sun GR, Pierce R, et al. Copper-64-Alloyed Gold Nanoparticles for Cancer Imaging: Improved Radiolabel Stability and Diagnostic Accuracy. Angew Chem Int Ed Engl. 2014; 53: 156-9.
27. Sun XL, Huang XL, Guo JX, Zhu WL, Ding Y, Niu G, et al. Self-illuminating Cu-64-Doped CdSe/ZnS Nanocrystals for in Vivo Tumor Imaging. J Am Chem Soc. 2014; 136: 1706-9.
28. Jensen AI, Binderup T, Kumar EKP, Kjaer A, Rasmussen PH, Andresen TL. Positron Emission Tomography Based Analysis of Long-Circulating Cross-Linked Triblock Polymeric Micelles in a U87MG Mouse Xenograft Model and Comparison of DOTA and CB-TE2A as Chelators of Copper-64. Biomacromolecules. 2014; 15: 1625-33.
29. Haque MM, Im HY, Seo JE, Hasan M, Woo K, Kwon OS. Acute toxicity and tissue distribution of CdSe/CdS-MPA quantum dots after repeated intraperitoneal injection to mice. J Appl Toxicol. 2013; 33: 940-50.
30. Singh S, Bingol B, Morgenroth A, Mottaghy FM, Moller M, Schmaljohann J. Radiolabeled Nanogels for Nuclear Molecular Imaging. Macromol Rapid Comm. 2013; 34: 562-7.
31. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008; 5: 505-15.
32. Moi MK, Meares CF, Mccall MJ, Cole WC, Denardo SJ. Copper-Chelates as Probes of Biological-Systems - Stable Copper-Complexes with a Macrocyclic Bifunctional Chelating Agent. Anal Biochem. 1985; 148: 249-53.
33. Anderson CJ, Rocque PA, Weinheimer CJ, Welch MJ. Evaluation of Copper-Labeled Bifunctional Chelate Albumin Conjugates for Blood Pool Imaging. Nucl Med Biol. 1993; 20: 461-7.
34. Vanasschen C, Bouslimani N, Thonon D, Desreux JF. Gadolinium DOTA Chelates Featuring Alkyne Groups Directly Grafted on the Tetraaza Macrocyclic Ring: Synthesis, Relaxation Properties, "Click" Reaction, and High-Relaxivity Micelles. Inorg Chem. 2011; 50: 8946-58.
35. Christensen LH, Breiting VB, Aasted A, Jorgensen A, Kebuladze I. Long-term effects of polyacrylamide hydrogel on human breast tissue. Plast Reconstr Surg. 2003; 111: 1883-90.
36. Berndt WO, Bergfeld WF, Boutwell RK, Carlton WW, Hoffmann DK, Schroeter AL, et al. Final Report on the Safety Assessment of Polyacrylamide. J Am Coll Toxicol. 1991; 10: 193-203.
37. Andersen FA. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics. Int J Toxicol. 2005; 24: 21-50.
38. Sjoholm I, Edman P. Acrylic Microspheres Invivo.1. Distribution and Elimination of Polyacrylamide Microparticles after Intravenous and Intra-Peritoneal Injection in Mouse and Rat. J Pharmacol Exp Ther. 1979; 211: 656-62.
39. Gupta A, Wang S, Marko A, Joshi P, Ethirajan M, Chen YH, et al. Polyacrylamide-Based Biocompatible Nanoplatform Enhances the Tumor Uptake, PET/fluorescence Imaging and Anticancer Activity of a Chlorophyll Analog. Theranostics. 2014; 4: 614-28.
40. Ait-Mohand S, Fournier P, Dumulon-Perreault V, Kiefer GE, Jurek P, Ferreira CL, et al. Evaluation of Cu-64-Labeled Bifunctional Chelate-Bombesin Conjugates. Bioconj Chem. 2011; 22: 1729-35.
41. Rex GC, Schlick S. Binding of Cu-2+ in Polyacrylamide Gels - an Electron-Spin Resonance Study. J Phys Chem. 1985; 89: 3598-601.
42. Jorgensen JT, Persson M, Madsen J, Kjaer A. High tumor uptake of Cu-64: Implications for molecular imaging of tumor characteristics with copper-based PET tracers. Nucl Med Biol. 2013; 40: 345-50.
43. Rashid OM, Nagahashi M, Ramachandran S, Dumur CI, Schaum JC, Yamada A, et al. Is tail vein injection a relevant breast cancer lung metastasis model? J Thorac Dis. 2013; 5: 385-92.
44. Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, et al. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem. 2004; 47: 1465-74.
45. Sun XK, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, et al. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J Med Chem. 2002; 45: 469-77.
46. 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biother Radiopharm. 2008; 23: 158-71.
47. 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. J Nucl Med. 2011; 52: 1110-8.
48. Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, et al. PET and SPECT Imaging of a Radiolabeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with Cu, Ga, and In. Mol Pharm. 2014.
49. Wang YC, Liu YJ, Luehmann H, Xia XH, Brown P, Jarreau C, et al. Evaluating the Pharmacokinetics and In Vivo Cancer Targeting Capability of Au Nanocages by Positron Emission Tomography Imaging. ACS Nano. 2012; 6: 5880-8.
50. Fukukawa KI, Rossin R, Hagooly A, Pressly ED, Hunt JN, Messmore BW, et al. Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. Biomacromolecules. 2008; 9: 1329-39.
51. Glaus C, Rossin R, Welch MJ, Bao G. In Vivo Evaluation of Cu-64-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent. Bioconj Chem. 2010; 21: 715-22.
52. Zhang ZY, Liu YJ, Jarreau C, Welch MJ, Taylor JSA. Nucleic acid-directed self-assembly of multifunctional gold nanoparticle imaging agents. Biomater Sci. 2013; 1: 1055-64.
53. Werner EJ, Datta A, Jocher CJ, Raymond KN. High-Relaxivity MRI Contrast Agents: Where Coordination Chemistry Meets Medical Imaging. Angew Chem Int Ed Engl. 2008; 47: 8568-80.
54. Manus LM, Strauch RC, Hung AH, Eckermann AL, Meade TJ. Analytical Methods for Characterizing Magnetic Resonance Probes. Anal Chem. 2012; 84: 6278-87.
55. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008; 452: 580-9.